Roche enjoys strong profit, expects growth in 2014

Published



GENEVA (AP) — Swiss drug maker Roche saw its full-year profits boosted by strong demand for its cancer medicines and diagnostic tests used by clinical laboratories, the company reported Thursday.

Roche, the world’s biggest manufacturer of cancer drugs, said it had net income of 11.2 billion Swiss francs ($12.4 billion) in 2013, an 18 percent rise against 9.5 billion francs the year before.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.